PHE_Scientific_Provision of purchase of SARS-CoV-2 (2019-nCoV) Spike RBD
Estimated value
£26k
Awarded value
£26k
Suppliers
1
Lots
1
Published
09 Apr 2021
Description
The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020. PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). Public Health England (PHE) has awarded a contract for the purchase of Spike RBD Antibody, Antigen Affinity Purified to Stratech Scientific Ltd, via direct award under PHE Microbiology Framework - Lot 2.
Scope
- Reference
- tender_126845/948788
- Total value
- £26,094 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Apr 2021 to 30 Mar 2022
- CPV classifications
- 33000000 33696200
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 01 Apr 2021, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£26k
Award date
31 Mar 2021
Contract start
01 Apr 2021
Contract end
30 Mar 2022